课题基金 / 基金详情

T-T COLLABORATION IN THE REJECTION OF ISLET ALLOGRAFTS

T-T COLLABORATION IN THE REJECTION OF ISLET ALLOGRAFTS
异体胰岛移植排斥中的 T-T 合作
批准号:
3132623
负责人:
DONALD BELLGRAU
金额:
$10.13万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-06-01 至 1989-05-31

项目摘要

项目成果

DONALD BELLGRAU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cultured islet cluster allografts were not rejected when placed under the kidney capsule of immunocompetent allogeneic recipients differing from the donor at the major histocompatibility complex (MHC). Rejection occurred if the recipients were injected with T cells from donors syngeneic to the recipient who had been previously primed to lymphoid cells of the graft donor haplotype. T cells from normal, unprimed donors did not induce rejection. Elimination of the cytotoxic/suppressor subset of T cells abrogated rejection. One conclusion of this result is that cytotoxic T lymphocytes (CTL) are necessary for graft rejection in this animal model system. The aim of the project is to determine whether the CTL are sufficient or if collaboration with other T cell subsets is required. The hypothesis to be tested is that CTL specific for the class I MHC alloantigens of the cultured islet allograft require help, most likely in the form of IL-2, from helper T cells specific for class I MHC antigens (class I specific helpers) and shed graft alloantigens represented in the context of the graft recipients MHC (physiologic helper). In this proposal an in vivo separation procedure (negative selection) is described. With negative selection the data presented show that it should be possible to distinguish, by function, CTL from class I specific and physiologic helpers. The data presented also will show that elimination, via negative selection, of all three subsets abolishes the capacity of the remaining T cells to induce rejection. By appropriate selection procedures, described in detail in the text, it will be possible to determine if the CTL subset by itself or in collaboration with other T cell subsets can induce graft rejection. This study, which uniquely identifies T cell subsets by function and specificity, should provide useful information on the general question of the mechanism of T cell mediated graft rejection.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
A requirement for the CD5 antigen in T cell activation.
T 细胞激活需要 CD5 抗原。
DOI: 10.1002/eji.1830180721
发表时间: 1988
期刊: European journal of immunology
影响因子: 5.4
作者: [McAteer,MJ, Lagarde,AC, Georgiou,HM, Bellgrau,D]
通讯作者: Bellgrau,D
Persistent immunogenicity of rat thymic epithelium.
大鼠胸腺上皮的持续免疫原性。
DOI: 10.1097/00007890-198908000-00023
发表时间: 1989
期刊: Transplantation
影响因子: 6.2
作者: [Georgiou,HM, Bellgrau,D]
通讯作者: Bellgrau,D
DOI: --
发表时间: 1987
期刊: Transplantation proceedings
影响因子: 0.9
作者: [Bellgrau,D, Hawkins,G, Babcock,S, Prowse,S]
通讯作者: Prowse,S
Cyclosporine-induced tolerance requires antigens capable of initiating an immune response.
环孢素诱导的耐受性需要能够启动免疫反应的抗原。
DOI: --
发表时间: 1987
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Haug,CE, Gill,RG, Babcock,SK, Lafferty,KJ, Bellgrau,D, Weil3rd,R]
通讯作者: Weil3rd,R
IMMUNOLOGY-IMMUNOTHERAPY
  • 批准号:
    7229225
  • 项目类别:
  • 资助金额:
    $1.24万
  • 财政年份:
    2006
  • 负责人:
    DONALD BELLGRAU
  • 依托单位:
Provoking anti-tumor immune responses with Fas ligand
  • 批准号:
    7161959
  • 项目类别:
  • 资助金额:
    $32.94万
  • 财政年份:
    2006
  • 负责人:
    DONALD BELLGRAU
  • 依托单位:
Provoking anti-tumor immune responses with Fas ligand
  • 批准号:
    7291653
  • 项目类别:
  • 资助金额:
    $33.54万
  • 财政年份:
    2006
  • 负责人:
    DONALD BELLGRAU
  • 依托单位:
IMMUNOLOGY AND IMMUNOTHERAPY
  • 批准号:
    6664437
  • 项目类别:
  • 资助金额:
    $25.04万
  • 财政年份:
    2002
  • 负责人:
    DONALD BELLGRAU
  • 依托单位:
海外基金